These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23824147)

  • 61. Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.
    Samimi S; Benoit B; Evans K; Wherry EJ; Showe L; Wysocka M; Rook AH
    Arch Dermatol; 2010 Dec; 146(12):1382-8. PubMed ID: 20713771
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.
    Nan XP; Zhang Y; Yu HT; Sun RL; Peng MJ; Li Y; Su WJ; Lian JQ; Wang JP; Bai XF
    Viral Immunol; 2012 Feb; 25(1):21-8. PubMed ID: 22233255
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PD-1/PD-L1 affects Graves progression through lymphocytes on the proliferation, apoptosis and inflammatory cytokine secretion of thyroid follicular epithelial cells.
    Han H; Fu X; Huang J; Zhang X; Yu J
    J Toxicol Sci; 2020; 45(11):701-711. PubMed ID: 33132244
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
    Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
    J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
    Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune phenotype of patients with stage IV metastatic inflammatory breast cancer.
    Fernandez SV; MacFarlane AW; Jillab M; Arisi MF; Yearley J; Annamalai L; Gong Y; Cai KQ; Alpaugh RK; Cristofanilli M; Campbell KS
    Breast Cancer Res; 2020 Dec; 22(1):134. PubMed ID: 33267869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study.
    Wilson JK; Zhao Y; Singer M; Spencer J; Shankar-Hari M
    Crit Care; 2018 Apr; 22(1):95. PubMed ID: 29661225
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of PD-1 on CD4+ T cells in peripheral blood associates with poor clinical outcome in non-small cell lung cancer.
    Zheng H; Liu X; Zhang J; Rice SJ; Wagman M; Kong Y; Zhu L; Zhu J; Joshi M; Belani CP
    Oncotarget; 2016 Aug; 7(35):56233-56240. PubMed ID: 27191652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon γ-producing T cells from apoptosis in patients with pulmonary tuberculosis.
    Singh A; Mohan A; Dey AB; Mitra DK
    J Infect Dis; 2013 Aug; 208(4):603-15. PubMed ID: 23661793
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of Foxp3+CD4+CD25+ regulatory T cells and Th1/Th2, Tc1/Tc2 profiles in the peripheral blood of patients with condyloma acuminatum.
    Xu Y; Zhu KJ; Zhu N; Jiang DH; Chen XZ; Cheng H
    Clin Exp Dermatol; 2009 Mar; 34(2):229-35. PubMed ID: 19077104
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro.
    Tay WT; Fang YH; Beh ST; Liu YW; Hsu LW; Yen CJ; Liu PY
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244307
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Platelets modulate CD4
    Paletta A; Di Diego García F; Varese A; Erra Diaz F; García J; Cisneros JC; Ludueña G; Mazzitelli I; Pisarevsky A; Cabrerizo G; López Malizia Á; Rodriguez AG; Lista N; Longueira Y; Sabatté J; Geffner J; Remes Lenicov F; Ceballos A
    Br J Haematol; 2022 May; 197(3):283-292. PubMed ID: 35076084
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uncovering CD4+ T-cell exhaustion in B-ALL.
    Gerdemann U; Alvarez-Calderon F
    Blood; 2022 Jul; 140(4):294-296. PubMed ID: 35900788
    [No Abstract]   [Full Text] [Related]  

  • 76. Extracellular vesicles mediated proinflammatory macrophage phenotype induced by radiotherapy in cervical cancer.
    Ren J; Li L; Yu B; Xu E; Sun N; Li X; Xing Z; Han X; Cui Y; Wang X; Zhang X; Wang G
    BMC Cancer; 2022 Jan; 22(1):88. PubMed ID: 35062905
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 1α,25(OH)
    Li Z; Xu B; Sun Y; Zhou L; Tao Y; Hou W; Bao J; Liu J; Fan W
    Bioengineered; 2022 Jan; 13(1):357-369. PubMed ID: 34974811
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The safety and efficacy of a novel method for treatment of HSIL.
    Zhao J; Feng H; Wang T; Pang X; Zhou Y; Cui Y
    Arch Gynecol Obstet; 2021 Nov; 304(5):1291-1298. PubMed ID: 33813597
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical Activity of Nivolumab for Human Papilloma Virus-Related Juvenile-Onset Recurrent Respiratory Papillomatosis.
    Creelan BC; Ahmad MU; Kaszuba FJ; Khalil FK; Welsh AW; Ozdemirli M; Grant NN; Subramaniam DS
    Oncologist; 2019 Jun; 24(6):829-835. PubMed ID: 30842242
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression and clinical significance of programmed death ligand 1 in nasopharyngeal carcinoma.
    Qu Y; Wang D; Yang L; Liu HY; Cui W; Che YQ
    Mol Clin Oncol; 2018 Jul; 9(1):75-81. PubMed ID: 29977542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.